Trial intelligence / Profile preview

Non-painful Endovenous Management of Propofol Administration

2018-001770-15Phase 4Active

Sponsor
Complejo Asistencial Universitario de León
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of propofol in Injection site pain (2 arms), sponsored by Complejo Asistencial Universitario de León. Primary endpoint: Pain after propofol administration. Started Nov 2019; status: active.

02

Drugs

propofol
03

Conditions

Injection site pain

Beyond the preview

Go deeper on 2018-001770-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-001770-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call